Pfizer expects $54 billion in 2022 sales on Covid vaccine and treatment pill
Pfizer expects to sell $32 billion of its Covid-19 shots and $22 billion of its antiviral coronavirus treatment pill Paxlovid.
Pfizer expects to sell $32 billion of its Covid-19 shots and $22 billion of its antiviral coronavirus treatment pill Paxlovid.
"We're optimistic for the balance of the year," Edgewell Personal Care CEO Rod Little told CNBC on Tuesday, as the company's stock sold off post-earnings.
Peloton on Tuesday slashed its financial outlook for the full year as the company announced CEO John Foley will be stepping down.
Peloton said it expects to slash roughly $800 million in annual costs and reduce capital expenditures by about $150 million this year.
The burrito chain is facing higher costs for labor and ingredients, but price hikes helped offset their impact.
President Joe Biden on Tuesday acknowledged Tesla and the company's status as the nation's largest producer of electric vehicles.
In Q1 2022, Spotify expects to report 418 million monthly active users. Analysts anticipated guidance of 417.8 million, according to StreetAccount.
Ford Motor reported earnings after the bell. Here are the results.
Amazon on Thursday reported a big beat on the top line in its fourth quarter results, driven by a gain on its stake in electric...